Dofetilide

In the US, Dofetilide (dofetilide systemic) is a member of the drug class group III antiarrhythmics and is used to treat Arrhythmia.

US matches:

• Dofetilide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01BD04

CAS registry number (Chemical Abstracts Service)

0115256-11-6

Chemical Formula

C19-H27-N3-O5-S2

Molecular Weight

441

Therapeutic Category

Antiarrhythmic agent

Chemical Names

3'-{2-[(4-Methylsulfonylaminophenethyl)methylamino]ethoxy}methansulfonanilid (IUPAC)

beta-[(p-Methanesulfonamidophenethyl)methylamino]methanesulfono-p-phenetidide (WHO)

Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)-

Foreign Names

• Dofetilidum (Latin)
• Dofetilid (German)
• Dofétilide (French)
• Dofetilida (Spanish)

Generic Names

• Dofetilide (OS: BAN, USAN)
• Dofétilide (OS: DCF)
• UK 68798 (IS: Pfizer)

Brand Name

• Tikosyn
  Pfizer, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.